FREE patent keyword monitoring and additional FREE benefits. /images/triangleright (1K) REGISTER now for FREE triangleleft (1K)
Fresh Patents
Monitor Patents Patent Organizer How to File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations
     new ** File a Provisional Patent ** 

Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |

Clark & Elbing LLP patents

keyword monitor Monitor "Clark & Elbing LLP" patents

The following is a sampling of recent Clark & Elbing LLP patent applications (USPTO Patent Application #, Patent Title) sorted by month.

April 2008 - Clark & Elbing LLP patents

20080095786 - Compositions and methods for preventing and treating endotoxin-related diseases and conditions
20080095803 - Protein matrix vaccines and methods of making and administering such vaccines
20080096841 - Treatment and prevention of heat shock protein-associated diseases and conditions
20080085237 - Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia
20080085835 - Rps gene family, primers, probes and detection methods
20080081097 - Phase transfer apparatus and process
20080081338 - Diagnostic method

March 2008 - Clark & Elbing LLP patents

20080075792 - Method for inhibiting the activity of dpp-iv and lowering blood glucose level
20080076674 - Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding rnas associated with cancer
20080069820 - Multispecific antibodies
20080070293 - Enzyme-based monitoring device for thermal processing of objects
20080064038 - Autism genes and regulated secretion
20080064081 - Structural protein of adeno-associated virus with modified antigenicity, its production and its use
20080064648 - Methods and compositions relating to lipid accumulation
20080064652 - Methods and compositions for treating hypercholesterolemia
20080064965 - Devices and methods for measuring pulsus paradoxus
20080058429 - Diagnosis of primary open angle glaucoma

February 2008 - Clark & Elbing LLP patents

20080051599 - Production of esters of fatty acids and lower alcohols
20080040941 - Measurement configuration based on linear scales able to measure to a target also moving perpendicular to the measurement axis
20080044390 - Methods and compositions for the treatment of neurodegenerative disorders
20080038234 - Bone marrow-related cells associated with tissue maintenance and/or repair
20080038249 - Treatment of neurodegenerative diseases by the use of laptm4a
20080039911 - Adhesion prevention and an intra-luminal cooling system therefor
20080040821 - Transgenic ungulates capable of human antibody production
20080028992 - Delayed-setting calcium phosphate pastes
20080031850 - Tissue regeneration method
20080031819 - Compositions and methods that enhance articular cartilage repair
20080031822 - Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine
20080031855 - Anticancer agent containing minus-strand rna virus
20080032955 - Vitamin d3 analogues for the prevention and treatment of bone disorders

January 2008 - Clark & Elbing LLP patents

20080025929 - Topical formulations for the treatment of skin conditions
20080025965 - Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein levels
20080025969 - Treatment of neurodegenerative diseases by the use of gpr49
20080026003 - Methods for inhibiting pain
20080020991 - Methods of treating, reducing, or preventing autoimmune conditions
20080021351 - Method for diagnosing adhd and related behavioral disorders
20080021564 - Humeral head resurfacing implant and methods of use thereof
20080014183 - Anticancer agent containing dendritic cell having rna virus transferred thereinto
20080015152 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
20080009010 - Methods for diagnosis and prognosis of psychotic disorders
20080009487 - Treatment of athersclerotic disease
20080003213 - Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
20080003256 - Biocompatible coating of medical devices
20080004285 - Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment

December 2007 - Clark & Elbing LLP patents

20070298015 - Treatment of muscular dystrophy with mobilized peripheral blood pluripotent cells
20070298029 - Treatment of neurodegenerative diseases by the use of degs inhibitors
20070298051 - Adjuvants of immune response
20070299010 - Cpg15 and cpg15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists
20070299043 - Anti-scarring drug combinations and use thereof
20070292426 - Methods and compositions based on shiga toxin type 1 protein
20070292851 - Methods for identifying candidate compounds for treating, reducing, or preventing pathogenic infections
20070293418 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
20070280927 - Treatment of neurodegenerative diseases by the use of atp7a
20070281329 - Characterization of individual polymer molecules based on monomer-interface interactions

November 2007 - Clark & Elbing LLP patents

20070274971 - Method of proliferating precursor cells
20070274991 - Treatment of tumors expressing mutant egf receptors
20070275015 - West nile virus vaccine
20070275068 - Controlled release delivery system for bio-active agents
20070275071 - Use of microparticles for antigen delivery
20070275380 - Method for distinguishing aml subtypes with aberrant and prognostically intermediate karyotypes
20070275416 - Affinity marker for purification of proteins
20070275900 - Prodrugs cleavable by cd26
20070269414 - Method for producing gene transferred denritic cells
20070269425 - Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use
20070269434 - Tat-041 and methods of assessing and treating cancer
20070269458 - Vaccines against japanese encephalitis virus and west nile virus
20070269539 - Ginkgo biloba extract as a treatment for therapeutic-induced neurotoxicity
20070269830 - Process for the identification of new medical targets
20070264244 - Pigment epithelial cell of the eye, its production and use in therapy of an eye or cns disease
20070264276 - Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
20070264306 - Scaffold engineering
20070264675 - Microfluidic device for cell separation and uses thereof
20070259358 - Integrase cofactor
20070259424 - Microfluidic device for cell separation and uses thereof
20070259816 - Drg11-responsive axonal guidance and outgrowth of neurite (dragon) gene family
20070259831 - Treatment and screening methods for promoting neurogenesis
20070259841 - Combinations for the treatment of rheumatoid arthritis
20070253939 - Cell delivery system
20070254002 - Biocompatible devices coated with activated protein c
20070254063 - Use of hop polyphenols in beer
20070254288 - Diagnostic methods for pain sensitivity and chronicity and for tetrahydrobiopterin-related disorders
20070254940 - 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
20070255254 - Cell delivery system

October 2007 - Clark & Elbing LLP patents

20070248574 - Methods of making and using skin-derived stem cells
20070248627 - Gene therapy for tumors using minus-strand rna viral vectors encoding immunostimulatory cytokines
20070248668 - Pharmaceutical compositions and uses thereof
20070249557 - Compositions and methods for viscosupplementation
20070244148 - Imidazo 4,5-c pyridine compounds and methods of antiviral treatment
20070244187 - Intermediates for the preparation of halichondrin b
20070238670 - Novel compositions and methods for promoting, inhibiting and detecting protein entry into cells
20070238684 - Aav scleroprotein, production and use thereof
20070238747 - Rifamycin analogs and uses thereof
20070231308 - Glucagon-like-peptide-2 (glp-2) analogues
20070231336 - Immunization against clostridium difficile disease
20070231851 - Microfluidic device for cell separation and uses thereof
20070231863 - Drg11-responsive axonal guidance and outgrowth of neurite (dragon) gene family

September 2007 - Clark & Elbing LLP patents

20070225217 - Methods, compositions, and kits for the treatment of medical conditions
20070219277 - Small molecules used to increase cell death
20070220620 - Tat-046 and methods of assessing and treating cancer
20070212733 - Methods and compositions related to b cell assays
20070212747 - Cassette containing growth medium
20070213296 - Compositions and methods for the treatment of immunoinflammatory disorders
20070213308 - Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith
20070213394 - Salvinorin derivatives and uses thereof
20070213964 - Method and device for predicting risk of decompression sickness
20070208134 - Anti-scarring drug combinations and use thereof

August 2007 - Clark & Elbing LLP patents

20070202546 - Immunoassay carrier
20070196418 - Drug delivery methods and devices
20070196421 - Soft tissue implants and drug combination compositions, and use thereof
20070196820 - Devices and methods for enrichment and alteration of cells and other particles
20070196878 - Immune diagnostic assay to diagnose and monitor tuberculosis infection
20070196917 - Methods of constructing a gene mutation library and compounds and compositions thereof
20070197957 - Implantable sensors, implantable pumps and anti-scarring drug combinations
20070198063 - Electrical devices and anti-scarring drug combinations
20070189942 - Sterilizer for medical devices
20070190575 - Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
20070192883 - Tat-028 and methods of assessing and treating cancer
20070192884 - Tat-038 and methods of assessing and treating cancer
20070192885 - Tat-039 and methods of assessing and treating cancer
20070192886 - Tat-044 and methods of assessing and treating cancer
20070192887 - Tat-042 and methods of assessing and treating cancer
20070181462 - A process for the production of needle coke
20070184052 - Soluble tgf-b type iii receptor fusion proteins
20070184544 - Culturing circular ssdna viruses for the production of vaccines
20070185018 - Use of secretin in treatments of disorders associated with the amygdala
20070185062 - Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
20070185343 - Metal complexes for use in olefin metathesis and atom group transfer reactions
20070186288 - Zebrafish models of acute myelogenous leukemia
20070186294 - Tat-030 and methods of assessing and treating cancer
20070186295 - Tat-036 and methods of assessing and treating cancer
20070175829 - Pressure driven separation of liquid feeds
20070179152 - Combination therapy for the treatment of neoplasms
20070179455 - Needle constructed with a transparent or translucent material
20070180545 - Tat-031 and methods of assessing and treating cancer

July 2007 - Clark & Elbing LLP patents

20070171225 - Time-dependent three-dimensional musculo-skeletal modeling based on dynamic surface measurements of bodies
20070172824 - Method for amplifying unknown dna sequence adjacent to known sequence
20070172853 - Use of deletion polymorphisms to predict, prevent, and manage histoincompatibility
20070172903 - Microfluidic device for cell separation and uses thereof
20070173466 - Methods of treating inflammatory diseases associated with bone destruction
20070173489 - Inhibitors of the gpib-vwf interaction, their preparation and use
20070166286 - Self-rearranging dna vectors
20070166702 - Methods for predicting the efficacy or outcome of hcv therapy
20070167409 - Compounds and methods for treating toll-like receptor 2-related diseases and conditions
20070169211 - Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
20070160503 - Microfluidic systems for size based removal of red blood cells and platelets from blood
20070160600 - Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
20070160607 - Humanized monoclonal antibodies that protect against shiga toxin induced disease
20070160953 - Method for manufacturing a prosthesis made prior to implant placement
20070161005 - Culturing circular ssdna viruses for the production of vaccines
20070161050 - Monoclonal antibodies to mesenchymal stem cells
20070161110 - Methods for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken beta-actin promoter
20070153652 - Recording and/or reproducing methods and apparatuses
20070153653 - Recording and/or reproducing methods and appratuses
20070154482 - Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
20070154904 - Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation
20070155715 - Rifamycin analogs and uses thereof

June 2007 - Clark & Elbing LLP patents

20070148733 - Yeast expression vectors for production of itf
20070149469 - Medical use of tbk-1 or of inhibitors thereof
20070141634 - Assay
20070141705 - Method for producing viral vectors
20070142392 - Uses of rifamycins
20070135337 - Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
20070128173 - Use of polysulphated alginate in cellular matrices
20070128245 - Porous calcium phosphate bone material
20070128591 - Methods for diagnosing and treating diseases and conditions of the digestive system and cancer

May 2007 - Clark & Elbing LLP patents

20070122340 - Necrosis avid tracer agent
20070122814 - Methods for distinguishing prognostically definable aml
20070123469 - N- or c- terminally modified small peptides
20070116688 - Methods of organ regeneration
20070117144 - Oligonucleotides useful for detecting and analyzing nucleic acids of interest
20070117163 - Anti-aurora-a monoclonal antibody, method for obtaining same and uses thereof for diagnosing and treating cancers
20070117752 - Glucagon-like-peptide-2 (glp-2) analogues
20070117836 - Napthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
20070110685 - Combination therapy for the treatment of immunoinflammatory disorders
20070110819 - Composite structures containing hyaluronic acid the derivatives thereof as new bone substitutes and grafts
20070111327 - Methods of detecting lubricin
20070111940 - Peptide agonists of glp-1 activity
20070112018 - Treatment of peripheral arterial occlusive disease
20070104699 - Compositions for and methods of granzyme b inhibition
20070104707 - Methods of diagnosing and treating complications of pregnancy
20070105167 - Virulence associated nucleic acid sequences and uses thereof
20070105208 - Minus strand rna virus vector carrying gene modified in high mutation region
20070105761 - Methods, compositions, and kits for the treatment of opthalmic disorders
20070105849 - Rifamycin analogs and uses thereof
20070106065 - Tat- 001 and methods of assessing and treating cancer
20070099196 - Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mrnas
20070099201 - Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids
20070099207 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070099289 - Device and method for contacting picoliter volumes of fluid
20070099905 - Combinations of drugs for the treatment of neoplasms
20070099906 - Combinations for the treatment of noeplastic disorders

April 2007 - Clark & Elbing LLP patents

20070087378 - Polynucleotide and polypeptide fat metabolism regulators and uses thereof
20070088248 - Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs and uses thereof
20070081999 - Antithrombotic von willebrand factor (vwf) collagen bridging blockers
20070082054 - Particle size reduction of bioactive compounds
20070082840 - Combination therapy for inhibition of platelet aggregation
20070078185 - Methods and compositions for controlling invertebrate pests

February 2007 - Clark & Elbing LLP patents

20070043000 - Immunosuppresive effects of pteridine derivatives
20070043002 - Aldolase-inhibiting aromatic compounds
20070043188 - Multicoordinated metal complexes for use in metathesis reactions
20070044167 - Method for producing avian chimera using spermatogonial cells and avian chimera
20070036756 - Method for treating ischemic diseases
20070037210 - Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same
20070037891 - Methods and compositions for the delivery of biologically active agents
20070031438 - Antibodies as chimeric effector cell receptors against tumor antigens
20070032477 - Pteridine derivatives useful for making pharmaceutical compositions
20070025914 - Bronchioalveolar stem cells and uses thereof
20070026381 - Devices and methods for enrichment and alteration of cells and other particles
20070026413 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026414 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026415 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026416 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026417 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026418 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026419 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026469 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070027103 - Methods and compositions for silencing genes without inducing toxicity
20070027127 - Treatment of inflammatory oral diseases with a combination of inhibitors of tnf-alpha and immunosuppressive agents

January 2007 - Clark & Elbing LLP patents

20070020285 - Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
20070015246 - Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
20070015718 - Diagnosis and management of infection caused by chlamydia
20070009592 - Immediate release pharmaceutical granule compositions and a continuous process for making them
20070009949 - Paramyxovirus-derived rnp
20070010502 - Methods and reagents for the treatment of immunoinflammatory disorders
20070010541 - Methods for treating vascular diseases
20070003560 - Humanized monoclonal antibodies that protect against shiga toxin induced disease
20070004623 - Use of hydroxylated amino acids for treating diabetes
20070004721 - Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases
20070004905 - Solid-phase peptide synthesis and agent for use in such synthesis
20070005139 - Tissue engineered tendons and ligaments

December 2006 - Clark & Elbing LLP patents

20060292149 - Variable antibodies
20060292179 - Vaccines for immunization against helicobacter
20060294603 - Cloning of transgenic animals comprising artificial chromosomes
20060283686 - Mobile gastronomic table for serving out food
20060286125 - Nucleic acid molecules and polypeptides for immune modulation
20060286167 - Compositions and methods for the treatment of neurodegenerative diseases
20060286177 - Methods and reagents for the treatment of inflammatory disorders
20060287314 - Immunosuppressive effects of pteridine derivatives
20060287503 - Retinoid x receptor-interacting polypeptides and related molecules and methods
20060280798 - Nanoparticles for delivery of a pharmacologically active agent
20060281046 - Stent for guiding the location/direction of implant, and production method thereof
20060281722 - Compounds and uses thereof
20060275748 - Integrase cofactor
20060276562 - Composite materials for bone defect filling and bone replacement

November 2006 - Clark & Elbing LLP patents

20060269520 - Xiap therapy
20060269944 - Mass intensity profiling system and uses thereof
20060269945 - Constellation mapping and uses thereof
20060270742 - Compositions and methods for the treatment of neurodegenerative diseases
20060263366 - Neoplasm specific antibodies and uses thereof
20060263859 - Method for preparing 3'-amino-2',3'-dideoxyguanosine
20060263876 - Neural crest stem cells and uses thereof
20060264384 - Compositions and methods for treatment for neoplasms
20060257381 - Method for transplanting lymphohematopoietic cells into mammal
20060257660 - Antistatic agent for vinyl chloride-based resins, vinyl chloride-based resin composition containing the same, and method for manufacturing this composition
20060257901 - Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
20060258721 - Substituted indole compounds having nos inhibitory activity
20060253014 - Methods for identifying anatomical and molecular targets for analgesic therapy
20060246031 - Use of cxcl6 chemokine in the prevention or repair cartilage defects
20060246046 - Modified tridegins, production and use thereof as transglutaminase inihibitors

October 2006 - Clark & Elbing LLP patents

20060239985 - Method of preparing cell for transplantation
20060239998 - Anti-idiotypic antibodies against factor viii inhibitor and uses thereof
20060240014 - Methods and compounds for the treatment of vascular stenosis
20060240037 - Methods and compositions for the treatment and prevention of degenerative joint disorders
20060240121 - Chemotherapeutic composition using nanocrystalline calcium phosphate paste
20060241122 - Combination therapy for the treatment of neoplasms
20060234991 - Combinations for the treatment of immunoinflammatory disorders
20060235001 - Compositions for the treatment of neoplasms
20060236411 - Antagonists il-15
20060228297 - Thorium-227 for use in radiotherapy of soft tissue disease
20060222655 - Compositions and methods for preventing and treating endotoxin-related diseases and conditions
20060223178 - Devices and methods for magnetic enrichment of cells and other particles
20060223733 - Compositions and methods for use in unclogging drains and pipes
20060223884 - Compounds and compositions for use in the prevention and treatment of obesity and related syndromes

September 2006 - Clark & Elbing LLP patents

20060216227 - Catalysts for hydrogen production
20060216824 - Paramyxovirus vector encoding ribozyme and utilization thereof
20060217344 - Compounds for the treatment of tobacco dependence and withdrawal
20060218657 - Method for improving germline transmission efficiency of avian primordial germ cells
20060211608 - Use of a parathyroid hormone peptide analogs for the treatment of viginal atrophy
20060212952 - Methods for cloning mammals using reprogrammed donor chromatin or donor cells
20060201504 - High-flow oxygen delivery system and methods of use thereof
20060204921 - Dental articulator having dual balls
20060205764 - Inhibition of platelet aggregation
20060199771 - Stereoselective antifibrillogenic peptides and peptidomimetics thereof
20060199853 - Analogs of 4-hydroxyisoleucine and uses thereof
20060200873 - Salicylic acid biosynthetic genes and uses thereof

August 2006 - Clark & Elbing LLP patents

20060191548 - Tobacco compositions
20060194201 - Autism gene
20060194719 - Stabilized exendin-4 compounds
20060194947 - Peptide gap junction modulators
20060195194 - Shoulder implant for glenoid replacement and methods of use thereof
20060185686 - Nicotiana diversity
20060188471 - Methods of treating epithelial lesions
20060188926 - Nucleic acid sequences and methods for identifying compounds that affect rna/rna binding protein interactions and mrna functionality
20060189526 - Compositions containing an intestinal trefoil peptide and a mucoadhesive
20060189563 - Detection and modulation of iaps and naip for the diagnosis and treatment of proliferative disease
20060189576 - Substituted vitamin d analogues and their therapeutic uses
20060189620 - Immunosuppressive effects of pteridine derivatives
20060183226 - Methods for retrotransposing long interspersed elements (lines)
20060183671 - Treatment of anemia
20060185030 - Cytokinin response regulators and uses thereof
20060177864 - Methods for identifying drug combinations for the treatment of proliferative diseases
20060177877 - Methods for identifying combinations of entities as therapeutics
20060178292 - Methods and compositions of ecdysozoan molt inhibition
20060178350 - 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes
20060172343 - Novel vegf-like factors
20060172348 - Use of neuronal apoptosis inhibitor protein (naip)

July 2006 - Clark & Elbing LLP patents

20060166238 - Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same
20060166277 - Nucleic acids and polypeptides useful for diagnosing and treating complications of pregnancy
20060166360 - Compositions, solutions, and methods used for transplantation
20060159670 - Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors
20060160145 - Epf receptor assays, compounds and therapeutic compositions
20060160867 - Methods for modulating ppar biological activity for the treatment of diseases caused by mutations in the cftr gene
20060153873 - Smallpox vaccine
20060147924 - Population of nucleic acids including a subpopulation of lna oligomers
20060147933 - Interspecies embryonic stem cell
20060148735 - Methods for treating, preventing, or reducing cardiac disorders using fadd inhibitors
20060148770 - Combinations for the treatment of rheumatoid arithritis
20060148901 - Acylated 4-amidino-and-4-guanidinobenzylamines for inhibition of plasma kallikrein
20060148926 - Bifunctionalized polyester material for surface treatment and biomodification
20060149028 - Diamine compound containing triazine group, polyamic acid synthesized from the diamine compound and lc alignment film prepared from the polyamic acid



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Clark & Elbing LLP in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Clark & Elbing LLP with additional patents listed. Browse our Agent directory for other possible listings.

###

FreshPatents.com Support